EMD Serono to Present Multiple Sclerosis Data on Cladribine Tablets and Evobrutinib at ACTRIMS 2019

[In The News]

ROCKLAND, Mass., Feb. 28, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, will present data at the fourth annual ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) Forum taking place...

View the full article